Handa Pharma (6620.TWO) monthly revenue, September 2026

Name: Handa Pharma (6620) monthly revenue 2026-09 | Value Ledger
Creator: Value Ledger
License: https://creativecommons.org/licenses/by/4.0/

Handa Pharma reported revenue of NT$0.07bn for September 2026, up 5.6% from the previous month and down 20.1% from a year earlier. Year-to-date revenue was NT$0.63bn, down 55.9% year on year. It ranked 132 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

Month	Revenue NT$bn	MoM %	YoY %
September 2026	0.07	5.6	-20.1